Effects of the components of hormone therapy on matrix metalloproteinases in breast- cancer cells: an in vitro study  Maher A. Abdallah, M.D., Huda I.

Slides:



Advertisements
Similar presentations
Lynn B. Davis, M. D. , M. S. , Sara J. Champion, M. S. , Steve O
Advertisements

Male infertility: a biomarker of individual and familial cancer risk
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Lynn B. Davis, M. D. , M. S. , Sara J. Champion, M. S. , Steve O
Age at menarche: a predictor of diminished ovarian function?
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Seven roads traveled well and seven to be traveled more
Akanksha Mehta, M.D., Mark Sigman, M.D.  Fertility and Sterility 
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Michael M. Alper, M.D.  Fertility and Sterility 
Hysterosalpingography with use of mobile C-arm fluoroscopy
Ovarian pregnancy after in vitro fertilization
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Sanghoon Lee, M. D. , Elke Heytens, Ph. D. , Fred Moy, Ph. D
In vitro effects of phthalate esters in human myometrial and leiomyoma cells and increased urinary level of phthalate metabolite in women with uterine.
Medical treatment of ectopic pregnancy: a committee opinion
In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors  Ahmad O. Hammoud, M.D.,
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers  Andrea.
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Predictive value of embryo grading for embryos with known outcomes
Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells  Kyong Wook.
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes  Jin-Ho Lim, M.D., Seong-Ho Yang,
Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M
Oocyte cryopreservation
Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain  Mohamed A. Bedaiwy,
Bradley J. Van Voorhis, M. D. , Rachel B. Mejia, D. O. , William D
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle  Nancy J. Kenney,
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for.
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Significant elevation of plasma matrix metalloproteinase-9 level and its ratio to matrix metalloproteinase-2 in patients with pelvic inflammatory disease 
Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation  Maher A. Abdallah, M.D.,
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Male infertility: a biomarker of individual and familial cancer risk
Clomiphene citrate at 50: the dawning of assisted reproduction
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study  Carlo.
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,
“Information-rich” reproductive outcomes in carriers of a structural chromosome rearrangement ascertained on the basis of recurrent pregnancy loss  Michelle.
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
In vitro fertilization and breast cancer: is there cause for concern?
Roberto Ensenat-Waser, Ph. D. , Antonio Pellicer, M. D. , Ph. D
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
S. Samuel Kim, M.D.  Fertility and Sterility 
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Efficacy of luteinizing hormone activity in patients undergoing in vitro fertilization and treated only with low-dose recombinant choriogonadotropin alfa.
Effect of gonadotropin-releasing-hormone-induced hypogonadism on insulin action as assessed by euglycemic clamp studies in men  Subodhsingh Chauhan, M.D.,
Fertility and Sterility: an evaluation
Paolo Moghetti, M.D.  Fertility and Sterility 
Association of endometriosis with body size and figure
Current evaluation of amenorrhea
Genetic evaluation procedures at sperm banks in the United States
Estrogen and progestogen therapy in postmenopausal women
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Soluble HLA-G in the peritoneal fluid of women with endometriosis
Are sperm DNA fragmentation, hyperactivation, and hyaluronan-binding ability predictive for fertilization and embryo development in in vitro fertilization.
Infertility induced by cancer treatment: inappropriate or no information provided to majority of French survivors of cancer  Julien Mancini, M.D., M.P.H.,
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization  Ginny Mounce,
Endometrial polyps affect uterine receptivity
Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced- stage endometriosis  You Jung Han, M.D., M.S., Han-Na Kim, M.S., Jin-Kook.
P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)
Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment  Daniel Bodri, M.D., M.Sc.,
Presentation transcript:

Effects of the components of hormone therapy on matrix metalloproteinases in breast- cancer cells: an in vitro study  Maher A. Abdallah, M.D., Huda I. Abdullah, M.S., Steven Kang, M.D., Douglas D. Taylor, Ph.D., Steven T. Nakajima, M.D., Cicek Gercel- Taylor, Ph.D.  Fertility and Sterility  Volume 87, Issue 4, Pages 978-981 (April 2007) DOI: 10.1016/j.fertnstert.2006.08.091 Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

FIGURE 1 Effect of E2 and Eq combined with the progestogens norethinderone acetate (N), medroxyprogesterone (M), and progesterone (P) on MMP-2 (A) and MMP-9 (B) in T47D and MCF-7 cells. Cells were incubated with 10 nM of E2 or Eq combined with 10 nM of the respective progestogens for 48 hours. Data are presented as the average of three zymography experiments analyzed by densitometry, and presented as a fraction of control ± SEM. *P<.05 compared to controls. Abdallah. HT induces MMPs in breast cancer cells. Fertil Steril 2007. Fertility and Sterility 2007 87, 978-981DOI: (10.1016/j.fertnstert.2006.08.091) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions